EULAR evidence-based recommendations for the management of fibromyalgia syndrome

S.F. Carville; S. Arendt-Nielsen; H. Bliddal; F. Blotman; J.C. Branco; D. Buskila; J.A.P. Da Silva; B. Danneskiold-Samsoe; F. Dincer; C. Henriksson; K.G. Henriksson; E. Kosek; K. Longley; G.M. McCarthy; S. Perrot; M. Puszczewicz; P. Sarzi-Puttini; A. Silman; M. Spath; E.H. Choy

doi:10.1136/ard.2007.071522

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

S.F. Carville, S. Arendt-Nielsen, H. Bliddal, F. Blotman, J.C. Branco, D. Buskila, J.A.P. Da Silva, B. Danneskiold-Samsoe, F. Dincer, C. Henriksson, K.G. Henriksson, E. Kosek, K. Longley, G.M. McCarthy, S. Perrot, M. Puszczewicz, P. Sarzi-Puttini, A. Silman, M. Spath, E.H. Choy

556 Citations (Scopus)

Abstract

Objective: To develop evidence-based recommendations for the management of fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords "fibromyalgia'', "treatment or management'' and "trial''. Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used to base recommendations on. When there was insufficient evidence from the literature, a Delphi process was used to provide basis for recommendation. Results: 146 studies were eligible for the review. 39 pharmacological intervention studies and 59 non-pharmacological were included in the final recommendation summary tables once those of a lower quality or with insufficient data were separated. The categories of treatment identified were antidepressants, analgesics, and "other pharmacological'' and exercise, cognitive behavioural therapy, education, dietary interventions and "other non-pharmacological''. In many studies sample size was small and the quality of the study was insufficient for strong recommendations to be made. Conclusions: Nine recommendations for the management of fibromyalgia syndrome were developed using a systematic review and expert consensus
Udgivelsesdato: 2008/4

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	67
Issue number	4
Pages (from-to)	536-541
Number of pages	5
ISSN	0003-4967
DOIs	https://doi.org/10.1136/ard.2007.071522
Publication status	Published - 2008

Access to Document

10.1136/ard.2007.071522

Cite this

Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Silva, J. A. P. D., Danneskiold-Samsoe, B., Dincer, F., Henriksson, C., Henriksson, K. G., Kosek, E., Longley, K., McCarthy, G. M., Perrot, S., Puszczewicz, M., Sarzi-Puttini, P., Silman, A., Spath, M., & Choy, E. H. (2008). EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases, 67(4), 536-541. https://doi.org/10.1136/ard.2007.071522

Carville, SF, Arendt-Nielsen, S, Bliddal, H, Blotman, F, Branco, JC, Buskila, D, Silva, JAPD, Danneskiold-Samsoe, B, Dincer, F, Henriksson, C, Henriksson, KG, Kosek, E, Longley, K, McCarthy, GM, Perrot, S, Puszczewicz, M, Sarzi-Puttini, P, Silman, A, Spath, M & Choy, EH 2008, 'EULAR evidence-based recommendations for the management of fibromyalgia syndrome', Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 536-541. https://doi.org/10.1136/ard.2007.071522

@article{593a43a0f84711ddb219000ea68e967b,

title = "EULAR evidence-based recommendations for the management of fibromyalgia syndrome",

abstract = "Objective: To develop evidence-based recommendations for the management of fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords {"}fibromyalgia'', {"}treatment or management'' and {"}trial''. Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used to base recommendations on. When there was insufficient evidence from the literature, a Delphi process was used to provide basis for recommendation. Results: 146 studies were eligible for the review. 39 pharmacological intervention studies and 59 non-pharmacological were included in the final recommendation summary tables once those of a lower quality or with insufficient data were separated. The categories of treatment identified were antidepressants, analgesics, and {"}other pharmacological'' and exercise, cognitive behavioural therapy, education, dietary interventions and {"}other non-pharmacological''. In many studies sample size was small and the quality of the study was insufficient for strong recommendations to be made. Conclusions: Nine recommendations for the management of fibromyalgia syndrome were developed using a systematic review and expert consensus Udgivelsesdato: 2008/4",

author = "S.F. Carville and S. Arendt-Nielsen and H. Bliddal and F. Blotman and J.C. Branco and D. Buskila and Silva, {J.A.P. Da} and B. Danneskiold-Samsoe and F. Dincer and C. Henriksson and K.G. Henriksson and E. Kosek and K. Longley and G.M. McCarthy and S. Perrot and M. Puszczewicz and P. Sarzi-Puttini and A. Silman and M. Spath and E.H. Choy",

note = "Times Cited: 6ArticleEnglishCarville, S. FKings Coll London, Weston Educ Ctr, Acad Rheumatol Unit, Sir Alfred Baring Garrod Clin Trials Unit, Cutcombe Rd, London SE5 9RJ, EnglandCited References Count: 63276DIB M J PUBLISHING GROUPBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLANDLONDON",

year = "2008",

doi = "10.1136/ard.2007.071522",

language = "English",

volume = "67",

pages = "536--541",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "4",

}

TY - JOUR

T1 - EULAR evidence-based recommendations for the management of fibromyalgia syndrome

AU - Carville, S.F.

AU - Arendt-Nielsen, S.

AU - Bliddal, H.

AU - Blotman, F.

AU - Branco, J.C.

AU - Buskila, D.

AU - Silva, J.A.P. Da

AU - Danneskiold-Samsoe, B.

AU - Dincer, F.

AU - Henriksson, C.

AU - Henriksson, K.G.

AU - Kosek, E.

AU - Longley, K.

AU - McCarthy, G.M.

AU - Perrot, S.

AU - Puszczewicz, M.

AU - Sarzi-Puttini, P.

AU - Silman, A.

AU - Spath, M.

AU - Choy, E.H.

N1 - Times Cited: 6ArticleEnglishCarville, S. FKings Coll London, Weston Educ Ctr, Acad Rheumatol Unit, Sir Alfred Baring Garrod Clin Trials Unit, Cutcombe Rd, London SE5 9RJ, EnglandCited References Count: 63276DIB M J PUBLISHING GROUPBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLANDLONDON

PY - 2008

Y1 - 2008

N2 - Objective: To develop evidence-based recommendations for the management of fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords "fibromyalgia'', "treatment or management'' and "trial''. Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used to base recommendations on. When there was insufficient evidence from the literature, a Delphi process was used to provide basis for recommendation. Results: 146 studies were eligible for the review. 39 pharmacological intervention studies and 59 non-pharmacological were included in the final recommendation summary tables once those of a lower quality or with insufficient data were separated. The categories of treatment identified were antidepressants, analgesics, and "other pharmacological'' and exercise, cognitive behavioural therapy, education, dietary interventions and "other non-pharmacological''. In many studies sample size was small and the quality of the study was insufficient for strong recommendations to be made. Conclusions: Nine recommendations for the management of fibromyalgia syndrome were developed using a systematic review and expert consensus Udgivelsesdato: 2008/4

AB - Objective: To develop evidence-based recommendations for the management of fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords "fibromyalgia'', "treatment or management'' and "trial''. Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used to base recommendations on. When there was insufficient evidence from the literature, a Delphi process was used to provide basis for recommendation. Results: 146 studies were eligible for the review. 39 pharmacological intervention studies and 59 non-pharmacological were included in the final recommendation summary tables once those of a lower quality or with insufficient data were separated. The categories of treatment identified were antidepressants, analgesics, and "other pharmacological'' and exercise, cognitive behavioural therapy, education, dietary interventions and "other non-pharmacological''. In many studies sample size was small and the quality of the study was insufficient for strong recommendations to be made. Conclusions: Nine recommendations for the management of fibromyalgia syndrome were developed using a systematic review and expert consensus Udgivelsesdato: 2008/4

U2 - 10.1136/ard.2007.071522

DO - 10.1136/ard.2007.071522

M3 - Journal article

C2 - 17644548

SN - 0003-4967

VL - 67

SP - 536

EP - 541

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 4

ER -